AGP Picks
View all

American Times Reporter
Provided by AGP

American Times Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Times Reporter.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 13, 2026

VERI EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Veritone (VERI) Investors of Securities Class Action Lawsuit Deadline on July 20, 2026
Jun. 13, 2026

VERI EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Veritone (VERI) Investors of Securities Class Action Lawsuit Deadline on July 20, 2026

Indeterminate GlobeNewswire
PHR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026
Jun. 13, 2026

PHR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

Indeterminate GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA
Jun. 13, 2026

ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – ADMA

Indeterminate GlobeNewswire
 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
Jun. 13, 2026

 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

Indeterminate GlobeNewswire
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
Jun. 13, 2026

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

Indeterminate GlobeNewswire
AIFA、ヒアルルート・コミュニケーション・グループに関連する株式取得取引について、正式な説明および反論を発表
Jun. 13, 2026

AIFA、ヒアルルート・コミュニケーション・グループに関連する株式取得取引について、正式な説明および反論を発表

Indeterminate GlobeNewswire
AIFA, HyalRoute 지분 인수 거래 관련 공식 해명 및 반박 발표
Jun. 13, 2026

AIFA, HyalRoute 지분 인수 거래 관련 공식 해명 및 반박 발표

Indeterminate GlobeNewswire
Penjelasan Rasmi dan Penafian oleh AIFA Berhubung Transaksi Pemerolehan Saham yang melibatkan HyalRoute Communication Group Limited
Jun. 13, 2026

Penjelasan Rasmi dan Penafian oleh AIFA Berhubung Transaksi Pemerolehan Saham yang melibatkan HyalRoute Communication Group Limited

Indeterminate GlobeNewswire
AIFA 就涉及 HyalRoute Communication Group Limited 的股份收購交易正式作出澄清及反駁
Jun. 13, 2026

AIFA 就涉及 HyalRoute Communication Group Limited 的股份收購交易正式作出澄清及反駁

Indeterminate GlobeNewswire
Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance
Jun. 13, 2026

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

Indeterminate GlobeNewswire
EpiCooler Product Information Updated As Consumer Interest In Portable AC Grows In 2026
Jun. 13, 2026

EpiCooler Product Information Updated As Consumer Interest In Portable AC Grows In 2026

Indeterminate GlobeNewswire
SPCL、IPO当日にスペースXへの2倍のエクスポージャーが設定されている米国初かつ唯一のETFとなる
Jun. 13, 2026

SPCL、IPO当日にスペースXへの2倍のエクスポージャーが設定されている米国初かつ唯一のETFとなる

Indeterminate GlobeNewswire
SPCL, 스페이스X 상장 첫날 2배 레버리지 투자 노출 제공하는 미국 최초·유일 ETF로 주목
Jun. 13, 2026

SPCL, 스페이스X 상장 첫날 2배 레버리지 투자 노출 제공하는 미국 최초·유일 ETF로 주목

Indeterminate GlobeNewswire
SPCL Menjadi ETF A.S. Pertama dan Satu-satunya Dengan Pendedahan 2X kepada SpaceX Pada Hari IPO
Jun. 13, 2026

SPCL Menjadi ETF A.S. Pertama dan Satu-satunya Dengan Pendedahan 2X kepada SpaceX Pada Hari IPO

Indeterminate GlobeNewswire
SPCL 成为 SpaceX 上市首日首个且唯一提供 2 倍杠杆风险敞口的美国 ETF
Jun. 13, 2026

SPCL 成为 SpaceX 上市首日首个且唯一提供 2 倍杠杆风险敞口的美国 ETF

Indeterminate GlobeNewswire
SPCL 成為首隻及唯一在上市首日即具 2 倍 SpaceX 曝險的美國交易所買賣基金
Jun. 13, 2026

SPCL 成為首隻及唯一在上市首日即具 2 倍 SpaceX 曝險的美國交易所買賣基金

Indeterminate GlobeNewswire
Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.
Jun. 13, 2026

Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.

Indeterminate GlobeNewswire
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jun. 13, 2026

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
Jun. 13, 2026

Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire
GRAL INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun. 13, 2026

GRAL INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

American Times Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.